Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases
Authors' conclusion
The higher correlation and reliability observed between SCORE2, PREVENT-CVD, and PREVENT-ASCVD in our series of CIRD patients followed over a 10-year period suggest that these scales may be largely interchangeable for identifying high-risk CIRD patients.
Study context
- Population
- Patients with chronic inflammatory rheumatic diseases (RA, AS, PsA) from 67 hospitals across Spain (CARdiovascular in RheuMAtology (CARMA) project), recruited July 2010–January 2012, 10-year follow-up
- Participants
- 2,080 patients
- Exposure
- QRISK3 vs SCORE2 vs PREVENT-CVD vs PREVENT-ASCVD 10-year cardiovascular disease (CVD) risk scores
- Outcome
- Predicted 10-year CV events, average across cohort
- Follow-up
- 10 years
Methodological detailsmulticentre
- Multicentre
Main finding
As reported in the abstract
QRISK3 and PREVENT-CVD predicted an average of ≈10% CV events
10 %
SCORE2 and PREVENT-ASCVD predicted an average of only 6.3%
6.3 %
Linear correlation coefficients between each pair of scales consistently above 0.8; average
0.9074
Observational data: associations, not effects.
Original publication
Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases. Semin Arthritis Rheum. Published 24 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →